Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Martinez

Showing results (351-360 of 367) with videos related to

Pageof 37
Sort By:
Chest|June 20, 2014
Prediction of acute respiratory disease in current and former smokers with and without COPDRussell P Bowler, Victor Kim, Elizabeth Regan, et al.
The Journal of Allergy and Clinical Immunology|June 18, 2014
A genome-wide survey of CD4(+) lymphocyte regulatory genetic variants identifies novel asthma genesSunita Sharma, Xiaobo Zhou, Derek M Thibault, et al.
The Journal of Allergy and Clinical Immunology|January 11, 2014
Genome-wide association study and admixture mapping identify different asthma-associated loci in Latinos: the Genes-environments & Admixture in Latino Americans studyJoshua M Galanter, Christopher R Gignoux, Dara G Torgerson, et al.
The Lancet. Infectious Diseases|November 26, 2021
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trialPeter G Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana-Arri, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 29, 2025
Pragmatic Evaluation of an Improvement Program for People Living With Modifiable High-Risk COPD Versus Usual Care: Protocols for the Cluster Randomized PREVAIL TrialKatherine Hickman, Yasir Tarabichi, Andrew P Dickens, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 27, 2022
Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?Ana Zabalza, Georgina Arrambide, Susana Otero-Romero, et al.
The Lancet. Respiratory Medicine|July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trialDonald P Tashkin, Michael D Roth, Philip J Clements, et al.
ERJ Open Research|October 1, 2025
Sex-specific genetic effects on susceptibility to idiopathic pulmonary fibrosisOlivia C Leavy, Anne F Goemans, Tamara Hernandez-Beeftink, et al.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Genome-wide SNP-sex interaction analysis of susceptibility to idiopathic pulmonary fibrosisOlivia C Leavy, Anne F Goemans, Amy D Stockwell, et al.
ERJ Open Research|February 20, 2024
Association study of human leukocyte antigen variants and idiopathic pulmonary fibrosisBeatriz Guillen-Guio, Megan L Paynton, Richard J Allen, et al.
Pageof 37

Showing results (351-360 of 367) with videos related to

Sort By:
Pageof 37
Chest|June 20, 2014
Prediction of acute respiratory disease in current and former smokers with and without COPDRussell P Bowler, Victor Kim, Elizabeth Regan, et al.
The Journal of Allergy and Clinical Immunology|June 18, 2014
A genome-wide survey of CD4(+) lymphocyte regulatory genetic variants identifies novel asthma genesSunita Sharma, Xiaobo Zhou, Derek M Thibault, et al.
The Journal of Allergy and Clinical Immunology|January 11, 2014
Genome-wide association study and admixture mapping identify different asthma-associated loci in Latinos: the Genes-environments & Admixture in Latino Americans studyJoshua M Galanter, Christopher R Gignoux, Dara G Torgerson, et al.
The Lancet. Infectious Diseases|November 26, 2021
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trialPeter G Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana-Arri, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 29, 2025
Pragmatic Evaluation of an Improvement Program for People Living With Modifiable High-Risk COPD Versus Usual Care: Protocols for the Cluster Randomized PREVAIL TrialKatherine Hickman, Yasir Tarabichi, Andrew P Dickens, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 27, 2022
Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?Ana Zabalza, Georgina Arrambide, Susana Otero-Romero, et al.
The Lancet. Respiratory Medicine|July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trialDonald P Tashkin, Michael D Roth, Philip J Clements, et al.
ERJ Open Research|October 1, 2025
Sex-specific genetic effects on susceptibility to idiopathic pulmonary fibrosisOlivia C Leavy, Anne F Goemans, Tamara Hernandez-Beeftink, et al.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Genome-wide SNP-sex interaction analysis of susceptibility to idiopathic pulmonary fibrosisOlivia C Leavy, Anne F Goemans, Amy D Stockwell, et al.
ERJ Open Research|February 20, 2024
Association study of human leukocyte antigen variants and idiopathic pulmonary fibrosisBeatriz Guillen-Guio, Megan L Paynton, Richard J Allen, et al.
Pageof 37